![](/img/cover-not-exists.png)
Idarubicin and intermediate-dose cytarabine for myeloid blast crisis of chronic myelogenous leukemia – results of a phase-II trial
F. Schneller, M. Schuler, K. Schumacher, J. Thaler, C. Peschel, C. Huber, W. AulitzkyVolume:
77
Language:
english
Pages:
5
DOI:
10.1007/s002770050447
Date:
November, 1998
File:
PDF, 68 KB
english, 1998